Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 69 of 1,261
  1. US 12194079

    Therapeutic regimen for the treatment of Fabry using stabilized alpha-galactosidase

    Protalix Ltd. · Granted Jan 14, 2025 · Expires Jan 9, 2045

    granted
  2. US 12194091

    Antibodies that bind human C6 and uses thereof

    REGENESANCE B.V. · Granted Jan 14, 2025 · Expires Jan 9, 2045

    granted
  3. US 12195439

    C1-substituted isopropylamine fused heterocyclic mescaline derivatives

    Enveric Biosciences Canada Inc. · Granted Jan 14, 2025 · Expires Jan 9, 2045

    granted
  4. US 12195724

    Methods of producing T cell populations enriched for stable regulatory T-cells

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 14, 2025 · Expires Jan 9, 2045

    granted
  5. US 12194138

    Devices and methods for delivering therapeutics

    Vertex Pharmaceuticals Incorporated · Granted Jan 14, 2025 · Expires Jan 9, 2045

    granted
  6. US 12195535

    Antibodies binding to VISTA at acidic pH

    Five Prime Therapeutics, Inc. · Granted Jan 14, 2025 · Expires Jan 9, 2045

    granted
  7. US 12195540

    Antibodies that bind integrin αvβ8 and uses thereof

    The Regents of the University of California · Granted Jan 14, 2025 · Expires Jan 9, 2045

    granted
  8. US 12195558

    Targeted delivery system and methods of use therefor

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Jan 14, 2025 · Expires Jan 9, 2045

    granted
  9. US 12195620

    Controlled entrapment and release of molecular cargo

    The Regents of the University of California · Granted Jan 14, 2025 · Expires Jan 9, 2045

    granted
  10. US 12195773

    PH20 polypeptide variants, formulations and uses thereof

    HALOZYME, INC. · Granted Jan 14, 2025 · Expires Jan 9, 2045

    granted
  11. US 12195804

    Treatment of squamous cell carcinoma

    The Board of Regents of the University of Texas System · Granted Jan 14, 2025 · Expires Jan 9, 2045

    granted
  12. US 12194065

    Methods and compositions to enhance metabolic detoxification systems

    Nature's Sunshine Products, Inc. · Granted Jan 14, 2025 · Expires Jan 9, 2045

    granted
  13. US 12195454

    Compounds for imaging tau proteins that accumulate in the brain

    National Institutes for Quantum and Radiological Science and Technology · Granted Jan 14, 2025 · Expires Jan 9, 2045

    granted
  14. US 12195766

    Tumor-selective E1a and E1b mutants

    The Regents of the University of California · Granted Jan 14, 2025 · Expires Jan 9, 2045

    granted
  15. US 12194016

    Methods of providing solriamfetol therapy to subjects with impaired renal function

    AXSOME MALTA LTD. · Granted Jan 14, 2025 · Expires Jan 9, 2045

    granted
  16. US 12194064

    Process of producing concentrated therapeutic phospholipid composition from krill extracts containing high level of free fatty acids

    Aker BioMarine Human Ingredients AS · Granted Jan 14, 2025 · Expires Jan 9, 2045

    granted
  17. US 12195447

    Azolopyrimidine for the treatment of cancer-related disorders

    Arcus Biosciences, Inc. · Granted Jan 14, 2025 · Expires Jan 9, 2045

    granted
  18. US 12194084

    Multi-subunit vaccines to elicit both MHC- and CD1-restricted T cell responses

    Northwestern University · Granted Jan 14, 2025 · Expires Jan 9, 2045

    granted
  19. US 12195453

    Antiproliferation compounds and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Jan 14, 2025 · Expires Jan 9, 2045

    granted
  20. US 12194090

    Tetanus vaccine platform for embedding COVID-19 vaccine

    Prime Bio, Inc. · Granted Jan 14, 2025 · Expires Jan 9, 2045

    granted
  21. US 12194082

    Compositions and methods for treatment of homocystinuria

    The Regents of the University of Colorado, a Body Corporate · Granted Jan 14, 2025 · Expires Jan 9, 2045

    granted
  22. US 12194061

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Jan 14, 2025 · Expires Jan 9, 2045

    granted
  23. IT 202300014295

    COMPOSIZIONI ORODISPERSIBILI COMPRENDENTI BETAMETASONE FOSFATO

    ALFASIGMA SPA [IT] · Granted Jan 12, 2025 · Expires Jan 7, 2045

    granted
  24. US 12187782

    PDL1 peptides for use in cancer vaccines

    IO Biotech ApS · Granted Jan 7, 2025 · Expires Jan 2, 2045

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.